Mucin Expression in Mucinous Pancreatic Cysts: Can String Sign Test Predict Mucin Types? A Single Center Pilot Study.
Journal
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
ISSN: 2148-5607
Titre abrégé: Turk J Gastroenterol
Pays: Turkey
ID NLM: 9515841
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
entrez:
7
5
2021
pubmed:
8
5
2021
medline:
12
2
2022
Statut:
ppublish
Résumé
Mucinous pancreatic cystic lesions (PCLs) express different mucin (MUC) types according to their histomorphologic types. High cystic fluid viscosity may help in the detection of mucinous PCLs. We hypothesized that high cystic fluid viscosity may be suggestive of a certain MUC type in mucinous PCLs. Prespecified MUC types (MUC1, MUC2, MUC4, MUC5AC, and MUC6) were evaluated in 18 definitively diagnosed mucinous PCLs with sufficient tissue material and prediagnostic cyst fluid viscosity evaluation-string sign (SS)-test. We evaluated the agreement of MUC expression with positive SS test results. Later, we compared cystic fluid carcinoembryonic antigen (CEA) between the prespecified MUC expressing and nonexpressing cyst types. A total of 18 mucinous PCL patients, 11 females, with mean age ± SD (59.7 ± 13.3) were included. Almost all malignant mucinous PCLs expressed MUC1 (71.4%) (P = .023). We found no significant agreement between the prespecified MUC types and positive SS, except MUC4 which had mild agreement. Also, no significant relation was found between cystic fluid CEA levels and MUC expression (P = .584). We did not detect a significantly moderate or good agreement between the prespecified MUC types and SS test. MUC1 was highly expressed in malignant mucinous cysts; however, it was incompatible with the SS test. MUC4 expression showed mild agreement with the SS test in a small number of patients.
Sections du résumé
BACKGROUND
Mucinous pancreatic cystic lesions (PCLs) express different mucin (MUC) types according to their histomorphologic types. High cystic fluid viscosity may help in the detection of mucinous PCLs. We hypothesized that high cystic fluid viscosity may be suggestive of a certain MUC type in mucinous PCLs.
METHODS
Prespecified MUC types (MUC1, MUC2, MUC4, MUC5AC, and MUC6) were evaluated in 18 definitively diagnosed mucinous PCLs with sufficient tissue material and prediagnostic cyst fluid viscosity evaluation-string sign (SS)-test. We evaluated the agreement of MUC expression with positive SS test results. Later, we compared cystic fluid carcinoembryonic antigen (CEA) between the prespecified MUC expressing and nonexpressing cyst types.
RESULTS
A total of 18 mucinous PCL patients, 11 females, with mean age ± SD (59.7 ± 13.3) were included. Almost all malignant mucinous PCLs expressed MUC1 (71.4%) (P = .023). We found no significant agreement between the prespecified MUC types and positive SS, except MUC4 which had mild agreement. Also, no significant relation was found between cystic fluid CEA levels and MUC expression (P = .584).
CONCLUSION
We did not detect a significantly moderate or good agreement between the prespecified MUC types and SS test. MUC1 was highly expressed in malignant mucinous cysts; however, it was incompatible with the SS test. MUC4 expression showed mild agreement with the SS test in a small number of patients.
Identifiants
pubmed: 33960943
doi: 10.5152/tjg.2020.20060
pmc: PMC8975460
doi:
Substances chimiques
Carcinoembryonic Antigen
0
Mucin-1
0
Mucin-2
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
187-193Références
Surgery. 2010 Oct;148(4):638-44; discussion 644-5
pubmed: 20797749
World J Gastrointest Oncol. 2016 Oct 15;8(10):725-734
pubmed: 27795812
Am J Cancer Res. 2017 Jun 01;7(6):1372-1383
pubmed: 28670497
Gastroenterology. 2018 Feb;154(3):576-584
pubmed: 29074452
Arch Pathol Lab Med. 2009 Mar;133(3):423-38
pubmed: 19260748
PLoS One. 2014 Apr 08;9(4):e93760
pubmed: 24714692
Pancreas. 2006 Nov;33(4):391-6
pubmed: 17079945
Am J Surg Pathol. 2015 Dec;39(12):1730-41
pubmed: 26559377
Mol Cancer. 2003 Jan 07;2:9
pubmed: 12556240
Turk J Gastroenterol. 2014 Feb;25(1):1-18
pubmed: 24918124
Endoscopy. 2015 Jul;47(7):626-31
pubmed: 25730281
Ann Surg Oncol. 2011 Jan;18(1):199-206
pubmed: 20717734
Clin Cancer Res. 2001 Dec;7(12):4033-40
pubmed: 11751498
Pancreatology. 2013 Nov-Dec;13(6):583-8
pubmed: 24280573
Pancreas. 2015 Jul;44(5):728-34
pubmed: 25906442
BMC Med Genomics. 2010 May 06;3:16
pubmed: 20459602
Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):607-20
pubmed: 23856888
Ann Surg. 1993 Jan;217(1):41-7
pubmed: 8424699
Virchows Arch. 2016 Nov;469(5):523-532
pubmed: 27591765